Journal of Cellular Biochemistry · 2024 · 10 citations · 33 references
Life SciencesOncologyPharmacologyApoptosisCellular MetabolismMolecular OncologyApoptosis In CancerApoptosis RegulationBcl-2 Family ProteinsCancer MetabolismFatty Acid MetabolismMetabolic Reprogramming In CancerBcl-2 Protein ExpressionBcl-2 Protein RegulationCancer Cell Proliferation InhibitionCell Cycle Arrest MechanismsFatty AcidsOmega-6 Fatty AcidsPro-apoptotic Bcl-2 ProteinsProapoptotic Bcl-2 Proteins
Medium-chain fatty acids (MCFAs) have 6-12 carbon atoms and are instantly absorbed into the bloodstream before traveling to the portal vein and the liver, where they are immediately used for energy and may have antitumor effects. Its role in breast cancer is poorly understood. To investigate the apoptosis-inducing effect of MCFAs in breast cancer cells, cell viability assay, colony formation assay, cell migration assay, cell invasion assay, nuclear morphology, cell cycle assay, intracellular reactive oxygen species (ROS), matrix metalloproteinase (MMP), apoptosis, RT-qPCR analysis, and Western blot analysis were performed. In the present study, MCFA treatments reduced proliferative capability, increased ROS level, increased the depletion of MMP, induced G0/G1 and S phase cell cycle arrest, and late apoptosis of breast cancer cells in an effective concentration. Besides, MCFA treatment contributed to the upregulation of proapoptotic protein (BAK) and caspase-3, and the downregulation of antiapoptotic protein (Bcl-2). Mechanistically, phosphorylation levels of EGFR, Akt, and mTOR were significantly reduced in breast cancer cells treated with MCFAs. However, no significant changes in apoptosis and signaling-related proteins were observed in lauric acid-treated ER-positive cancer cells. Our findings suggested that MCFAs suppressed breast cancer cell proliferation by modulating the PI3K/Akt/mTOR signaling pathway. MCFAs may be a promising therapeutic drug for treating breast cancer.
33
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Anne Brunet, Azad Bonni, Michael J. Zigmond et al. · Cell · 1999 · 6.6K citations · Full text
Christina Fitzmaurice, Christine A. Allen, Ryan M Barber et al. · JAMA Oncology · 2016 · 6.3K citations · Full text
Christina Fitzmaurice · Journal of Clinical Oncology · 2018 · 1.7K citations · Full text
Medicine, Health Policy, Oncology +17